Johns Hopkins Medicine/Surescripts Piloting RTPB Standard
To Speed Time to Medication Therapy and Improve Adherence
Johns Hopkins Medicine, in partnership with Surescripts, received a $50,000 NCPDP Foundation grant for a study on the Beta Version of NCPDP’s Real-Time Prescription Benefit (RTPB) Standard. This new standard provides a standardized format for the prescriber, pharmacy and pharmacy claims processor to exchange real-time information about a patient’s drug benefit coverage and out-of-pocket cost prior to prescribing and dispensing. The ability to instantly access this data at the point of prescribing provides unprecedented transparency that will allow the physician, together with the patient, to make more informed decisions about a treatment plan. This can increase speed to therapy and have a positive impact on medication adherence and health outcomes.
University of Wisconsin Studying CancelRx Transaction
For Potential to Help Abate Opioid Crisis
A $36,000 Foundation-funded project at the University of Wisconsin (UW) is studying the effectiveness of CancelRx, an underused transaction in the NCPDP SCRIPT Standard for ePrescribing that can help curb the national opioid crisis by preventing the dispensing of medications that are discontinued by the physician. The CancelRx transaction enables prescribers to send a message electronically to the pharmacy to cancel a patient’s prescription. These medication discontinuation orders generally are not electronically communicated to the pharmacy, putting patients at risk of serious adverse drug events and errors. The UW study will show whether the Cancel Rx electronic transaction can minimize the number of extraneous or unnecessary controlled substance medications that are dispensed and available to patients.
Johns Hopkins Studying Patient Benefit From Physician Use
of Electronic Transaction to Cancel Prescriptions
Johns Hopkins Medicine has received two NCPDP Foundation grants for research demonstrating the value of implementing the underused Cancel Rx transaction in ePrescribing. The first study produced recommendations for potential enhancements to the CancelRx message that can maximize patient safety and usability. Most recently, the NCPDP Foundation co-funded with the NACDS Foundation another $52,000 grant. The Johns Hopkins study now underway will establish a method to measure the clinical benefit of using the CancelRx transaction to discontinue dispensing a prescription that is no longer useful to the patient and may be harmful if continued. Development of this method is essential to evaluate the impact of the broader rollout of CancelRx on medication safety through partnerships with community pharmacies.
Pharmacist eCare Plan Allowing Pharmacists
To Become Key Part of Patient Care Team
An NCPDP Foundation grant of $25,000 to the NCPA Innovation Center helped fund completion of the Implementation Guide for the Pharmacist eCare Plan (PeCP). This paved the way for a collaborative effort between NCPDP and Health Level Seven International (HL7) – both standards organizations -- to obtain approval of the PeCP as a standard accredited by the American National Standards Institute (ANSI). The standard would help enable pharmacists to become a key part of the patient care team. It allows pharmacy technology providers to have a common method of exchanging information related to care delivery, including patient goals, health concerns, active medication list, drug therapy problems, laboratory results, vitals, payer information and billing for services.